<SUBMISSION>
<ACCESSION-NUMBER>0000718937-05-000028
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>3
<PERIOD>20050407
<ITEMS>1.01
<ITEMS>7.01
<FILING-DATE>20050413
<DATE-OF-FILING-DATE-CHANGE>20050413
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>STAAR SURGICAL CO
<CIK>0000718937
<ASSIGNED-SIC>3851
<IRS-NUMBER>953797439
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>0101
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-11634
<FILM-NUMBER>05748367
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1911 WALKER AVE
<CITY>MONROVIA
<STATE>CA
<ZIP>91016
<PHONE>6263037902
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1911 WALKER AVE
<CITY>MONROVIA
<STATE>CA
<ZIP>91016
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>STAAR SURGICAL COMPANY
<DATE-CHANGED>19920703
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k04072005_staar.htm
<DESCRIPTION>FORM 8-K APRIL 7, 2005
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
     <!-- Created by EDGAR Ease Plus (EDGAR Ease+) -->
</HEAD>

<BODY>
<A name=A001></A>
<H1 align=center><FONT face="Times New Roman, Times, Serif" size=2>UNITED STATES <BR>SECURITIES AND EXCHANGE COMMISSION<BR>Washington, D.C. 20549 </FONT></H1>

<!-- MARKER FORMAT-SHEET="Head Major Center Bold-TNR" FSL="Workstation" -->
<A name=A004></A>
<H1 align=center><FONT face="Times New Roman, Times, Serif" size=2>FORM 8-K </FONT></H1>

<!-- MARKER FORMAT-SHEET="Head Major Center Bold-TNR" FSL="Workstation" -->
<A name=A005></A>
<H1 align=center><FONT face="Times New Roman, Times, Serif" size=2>CURRENT REPORT <BR>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 </FONT></H1>

<!-- MARKER FORMAT-SHEET="Head Minor Center-TNR" FSL="Workstation" -->
<A name=A007></A>
<P align=center><FONT face="Times New Roman, Times, Serif" size=2>Date of Report (Date of earliest event reported): April 7, 2005 </FONT></P>

<!-- MARKER FORMAT-SHEET="Head Major Center Bold-TNR" FSL="Workstation" -->
<A name=A008></A>
<H1 align=center><FONT face="Times New Roman, Times, Serif" size=3>STAAR SURGICAL COMPANY </FONT></H1>

<!-- MARKER FORMAT-SHEET="Head Minor Center-TNR" FSL="Default" -->
<A name=A009></A>
<P align=center><FONT face="Times New Roman, Times, Serif" size=2>(Exact name of registrant as specified in its charter) </FONT></P>

<TABLE cellSpacing=0 cellPadding=0 width=600 align=center border=0>
<TR vAlign=bottom>
<TH></TH>
<TH></TH>
<TH></TH></TR>
<TR vAlign=bottom>
<TD align=center width="33%"><FONT face="Times New Roman, Times, Serif" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delaware</FONT></TD>
<TD align=center width="33%"><FONT face="Times New Roman, Times, Serif" size=2>0-11634</FONT></TD>
<TD align=center width="34%"><FONT face="Times New Roman, Times, Serif" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;95-3797439</FONT></TD></TR>
<TR vAlign=bottom>
<TD align=center><FONT face="Times New Roman, Times, Serif" size=1>&nbsp;&nbsp;(State or other jurisdiction</FONT></TD>
<TD align=center><FONT face="Times New Roman, Times, Serif" size=1>(Commission File Number)</FONT></TD>
<TD align=center><FONT face="Times New Roman, Times, Serif" size=1>(I.R.S. Employer Identification No.)</FONT></TD></TR>
<TR vAlign=bottom>
<TD align=center><FONT face="Times New Roman, Times, Serif" size=1>of incorporation or organization)</FONT></TD>
<TD align=center><FONT face="Times New Roman, Times, Serif" size=1></FONT></TD></TR>
<TR>
<TD align=center><FONT face="Times New Roman, Times, Serif" size=1></FONT></TD></TR>
</TABLE>

<BR>
<!-- MARKER FORMAT-SHEET="Head Minor Center-TNR" FSL="Project" -->
<P align=center><FONT face="Times New Roman, Times, Serif" size=2>1911 Walker Avenue,&nbsp;Monrovia,&nbsp;California,&nbsp;&nbsp;&nbsp;91016</FONT><BR><FONT face="Times New Roman, Times, Serif" size=1>(Address of principal executive offices)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Zip Code) </FONT></P>
<BR>
<!-- MARKER FORMAT-SHEET="Head Minor Center-TNR" FSL="Workstation" -->
<A name=A010></A>
<P align=center><FONT face="Times New Roman, Times, Serif" size=2>(626) 303-7902 </FONT><BR><FONT face="Times New Roman, Times, Serif" size=1>(Registrant&#146;s telephone number, including area code) </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Default" -->

<P><FONT face="Times New Roman, Times, Serif" size=2>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </FONT></P>


<P><FONT face="Times New Roman, Times, Serif" size=2>[&nbsp;&nbsp;&nbsp;] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT>
<!-- MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Workstation" -->

<P><FONT face="Times New Roman, Times, Serif" size=2>[&nbsp;&nbsp;&nbsp;] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Workstation" -->

<P><FONT face="Times New Roman, Times, Serif" size=2>[&nbsp;&nbsp;&nbsp;] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Default" -->

<P><FONT face="Times New Roman, Times, Serif" size=2>[&nbsp;&nbsp;&nbsp;] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></P>

<!-- MARKER PAGE="sheet: 1; page: 1" -->

<PAGE>

<HR color=gray noShade SIZE=5>

<!-- MARKER FORMAT-SHEET="Head Major Left Bold-TNR" FSL="Workstation" -->
<A name=A012></A>
<H1 align=left><FONT face="Times New Roman, Times, Serif" size=2>Item 1.01 Entry into a Material Definitive Agreement </FONT></H1>

<!-- MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Workstation" -->

<P><FONT face="Times New Roman, Times, Serif" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On April 7, 2005, STAAR Surgical Company (the &#147;Company&#148;) paid discretionary bonuses to the Company&#146;s Chief Executive Officer and Named Executive Officers for fiscal 2004. Bonuses generally are based upon the achievement of corporate goals such as: (i) the Company&#146;s revenue and net income results versus the prior year; and (ii) the performance of the Company as compared to its industry. In addition, an element of the total bonus awarded may relate to the performance of the individual against preset personal objectives.&nbsp; A greater percentage of the senior officers' total bonus is based upon the acheivement of corporate objectives versus the achievement of preset personal objectives. </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Workstation" -->

<P><FONT face="Times New Roman, Times, Serif" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company paid a discretionary bonus of $50,000 to David Bailey, the Company&#146;s Chief Executive Officer. This is based on Mr. Bailey&#146;s development and implementation of a comprehensive plan to improve the Company&#146;s international operations and achieving a 38% increase in sales of the ICL in international markets. Mr. Bailey was also granted an option to purchase 150,000 shares of the Company&#146;s Common Stock at an exercise price of $3.95. </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Workstation" -->

<P><FONT face="Times New Roman, Times, Serif" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, the Company paid discretionary bonuses to the following Named Executive Officers in the following amounts: (i) John Bily, $50,000, equivalent to 20% of Mr. Bily&#146;s base salary, due to Mr. Bily&#146;s key role in the management of global finance and SEC compliance &#150; this leadership and focus allowed the Company to complete its compliance with Section 404 of the Sarbanes-Oxley Act of 2002 successfully; (ii) Nicholas Curtis, $34,950, equivalent to 15% of Mr. Curtis&#146; base salary, due to Mr. Curtis&#146; role in setting up the ICL training group and marketing plan ahead of the U.S. launch of the ICL pending FDA approval; (iii) Thomas Paul, $41,250, equivalent to 25% of Mr. Paul&#146;s base salary, due to Mr. Paul&#146;s key role in strengthening the Company&#146;s collamer manufacturing process and overall compliance on a global basis, in particular at the Company&#146;s Nidau
facility; and (iv) Guenther Roepstorff, $90,821, equivalent to 25% of Mr. Roepstorff&#146;s base salary, due to Mr. Roepstorff&#146;s management of the Company&#146;s German operations, which had a net income increase of 43% for 2004 compared to 2003. Mr Bily, Mr. Curtis, Mr. Paul and Mr. Roepstorff were also granted options to purchase 35,000, 25,000, 50,000 and 25,000 shares of the Company&#146;s Common Stock, respectively, at an exercise price of $3.95.&nbsp; The reasons mentioned above for the granting of discretionary bonuses are a few examples of the achieved preset personal objectives considered by the Nominating, Governance&nbsp;and Compensation Committee of STAAR Surgical Company.</FONT></P>


<P><FONT face="Times New Roman, Times, Serif" size=2><B>Item 7.01 Regulation FD Disclosure</B> </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Workstation" -->

<P><FONT face="Times New Roman, Times, Serif" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On April 11, 2005, the Company issued a press release announcing the closing of the sale of 4.1 million shares of its Common Stock at $3.50 per share, for gross proceeds of $14.35 million in a private placement to certain institutional investors. A copy of the press release is attached as Exhibit 99.1 to this report and is incorporated herein by reference. </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Workstation" -->

<P><FONT face="Times New Roman, Times, Serif" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, will not be treated as filed for the purposes of Section 18 of the Securities Exchange Act of 1934 (the &#147;Exchange Act&#148;) or otherwise subject to the liabilities of that section. This information will not be incorporated by reference into a filing under the Securities Act of 1933, or into another filing under the Exchange Act, unless that filing expressly refers to specific information in this report. The furnishing of the information in this Item 7.01 of this Current Report is not intended to and does not, constitute a representation that such furnishing is required by Regulation FD or that the information this Item 7.01 contains is material investor information that is not otherwise publicly available. </FONT></P>

<!-- MARKER FORMAT-SHEET="Head Major Left Bold-TNR" FSL="Default" -->
<A name=A014></A>
<H1 align=left><FONT face="Times New Roman, Times, Serif" size=2>Item 9.01. Financial Statements and Exhibits. </FONT></H1>

<TABLE cellSpacing=0 cellPadding=0 border=0>
<TR vAlign=bottom>
<TH><FONT face="Times New Roman, Times, Serif" size=2>Exhibit Number</FONT></TH>
<TH><FONT face="Times New Roman, Times, Serif" size=2></FONT></TH>
<TH><FONT face="Times New Roman, Times, Serif" size=2>Description</FONT></TH></TR>
<TR vAlign=top>
<TD align=center><FONT face="Times New Roman, Times, Serif" size=2>99.1</FONT></TD>
<TD><FONT face="Times New Roman, Times, Serif" size=2></FONT></TD>
<TD><FONT face="Times New Roman, Times, Serif" size=2>
<A href="f8k040705ex99-1.htm">Press release dated April 11, 2005</A>.</FONT></TD></TR>
</TABLE>


<!-- MARKER FORMAT-SHEET="Head Major Center Bold-TNR" FSL="Workstation" -->
<A name=A015></A>
<H1 align=center><FONT face="Times New Roman, Times, Serif" size=2>SIGNATURES </FONT></H1>

<!-- MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Default" -->

<P><FONT face="Times New Roman, Times, Serif" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </FONT></P>

<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>
<TR vAlign=top>
<TD width="10%"><FONT face="Times New Roman, Times, Serif" size=2>Date:</FONT></TD>
<TD width="40%"><FONT face="Times New Roman, Times, Serif" size=2>April 13, 2005 </FONT></TD>
<TD width="50%"><FONT face="Times New Roman, Times, Serif" size=2><B>STAAR SURGICAL COMPANY </B><BR><BR><BR>By: /s/ John Bily <BR>&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;<BR>John Bily <BR>Chief Financial Officer </FONT></TD></TR>
</TABLE>


</BODY>

</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>f8k040705ex99-1.htm
<DESCRIPTION>FORM 8K APRIL 7, 2005 EX99.1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
     <!-- Created by EDGAR Ease Plus (EDGAR Ease+) -->
</HEAD>

<BODY><P align=right><FONT face="Times New Roman, Times, Serif" size=2><B>Exhibit 99.1 </B></FONT></P>

<P align=right><IMG src="logosmall.jpg"></P>

<TABLE cellSpacing=0 cellPadding=0 width=600 border=0>
<TR vAlign=bottom>
<TH><FONT face="Times New Roman, Times, Serif" size=2></FONT></TH>
<TH><FONT face="Times New Roman, Times, Serif" size=2></FONT></TH>
<TH><FONT face="Times New Roman, Times, Serif" size=2></FONT></TH></TR>
<TR vAlign=bottom>
<TD align=left width="20%"><FONT face="Times New Roman, Times, Serif" size=2><B>CONTACT:</B></FONT></TD>
<TD align=left width="40%"><FONT face="Times New Roman, Times, Serif" size=2><B>Investors</B></FONT></TD>
<TD align=left width="40%"><FONT face="Times New Roman, Times, Serif" size=2><B>Media</B></FONT></TD></TR>
<TR vAlign=bottom>
<TD align=left><FONT face="Times New Roman, Times, Serif" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD align=left><FONT face="Times New Roman, Times, Serif" size=2>EVC GROUP</FONT></TD>
<TD align=left><FONT face="Times New Roman, Times, Serif" size=2>EVC GROUP</FONT></TD></TR>
<TR vAlign=bottom>
<TD align=left><FONT face="Times New Roman, Times, Serif" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD align=left><FONT face="Times New Roman, Times, Serif" size=2>Douglas Sherk, (415) 896-6820</FONT></TD>
<TD align=left><FONT face="Times New Roman, Times, Serif" size=2>Chris Toth, (415) 896-6820</FONT></TD></TR>
<TR vAlign=bottom>
<TD align=left><FONT face="Times New Roman, Times, Serif" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD align=left><FONT face="Times New Roman, Times, Serif" size=2>Jennifer Beugelmans, (415) 896-6820</FONT></TD></TR>
</TABLE>

<BR>
<!-- MARKER FORMAT-SHEET="Head Sub 1 Left-TNR" FSL="Workstation" -->
<A name=A001></A>
<P align=center><FONT face="Times New Roman, Times, Serif" size=2><B>&nbsp;&nbsp;&nbsp;STAAR SURGICAL ANNOUNCES CLOSING OF COMMON STOCK OFFERING</B></FONT></P>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Workstation" -->

<P><FONT face="Times New Roman, Times, Serif" size=2>MONROVIA, Calif., April 11, 2005 &#151; STAAR Surgical Company (Nasdaq: STAA) today announced that it has closed the sale of 4.1 million shares of its common stock at $3.50 per share, for gross proceeds of $14.35 million in a private placement to certain institutional investors. Pacific Growth Equities, LLC acted as the exclusive placement agent for the transaction. </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Workstation" -->

<P><FONT face="Times New Roman, Times, Serif" size=2>This release is not an offer to sell, or a solicitation of an offer to buy securities, nor shall there be any sale of the company&#146;s securities in any state in which such offer, solicitation or sale would be unlawful prior to their registration or qualification under the securities laws of any such state. </FONT></P>

<!-- MARKER FORMAT-SHEET="Head Left-TNR" FSL="Workstation" -->
<A name=A002></A>
<P align=left><FONT face="Times New Roman, Times, Serif" size=2><U><B>About STAAR Surgical</B></U> </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Workstation" -->

<P><FONT face="Times New Roman, Times, Serif" size=2>STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR&#146;s products are used by ophthalmic surgeons to improve the vision of patients. </FONT></P>

<!-- MARKER FORMAT-SHEET="Head Left-TNR" FSL="Workstation" -->
<A name=A003></A>
<P align=left><FONT face="Times New Roman, Times, Serif" size=2><B><U>Safe Harbor</U></B> </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Default" -->

<P><FONT face="Times New Roman, Times, Serif" size=2>All statements in this news release that are not statements of historical fact are forward-looking statements. These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. The risks and uncertainties include The risks and uncertainties include those detailed from time to time in STAAR Surgical Company&#146;s reports filed with the Securities and Exchange Commission. STAAR Surgical Company assumes no obligation to update these forward-looking statements, and does not intend to do so. </FONT></P>

<!-- MARKER FORMAT-SHEET="Center Rule" FSL="Default" -->
<P align=center>_________________ </P>

</BODY>

</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logosmall.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logosmall.jpg
M_]C_X``02D9)1@`!`0$`2`!(``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`!:`,8#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#WN5W1-R1E
M\=5!P<>U00:E:W#K&LFV5LXC?Y6..N/7'?&<=ZMUEZII$=\C-'Y:3G!/F)NC
MDQT#KW]CU'8]09E=:H:MU-2BN.M[C4(+MK.UO#;7R\_V?J+&6.0>L4OWB/SQ
MZ#%6/^$P:PE$.MZ5<V+$X$B_O(S]".OT&:A5H]=/Z_K<OV;Z'4T5FVGB#2;[
M'V?4+=F;HC/M;_ODX-:0.:T4D]40TUN123;)X8_^>A/Z#-2UB:G=&/Q)HL`(
MPYF+>WR8'YDUMTHN[:!JR0454NM3L;'_`(^KRW@/I)(%/Y5B7'C?3_-\C3H+
MG4+@CY4AC('Z\_B`:4JD([L:A)[(Z:H9[N"U"^=(%+<*O5F/H`.3^%<O>ZEJ
MHB234KA-+CE.(K2T`FNIC_=!/`/3D#OSBKVEZ(6S<7T(C+`?Z.7,C'WED/,A
M]ONCT.`:E5')VBA\EE=LV+>Z^U#?'&1$?NNQ^][@>GO5BBBM40%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`&?J^CVNLVGD7*D%3NCD7AHV]0:YA-;N=&
MN#H_B>-;FVD'[NZ*;@Z_[0[^_<=\YS7;U1U;2K;6;![2Y!VGE7'WD;L1652#
M?O1W_,N$EM+8YZ_\#:5J$0GTZ8V^\;E*'S(F![XS_(X]JYRX\,^(]'RUJ9GC
M'\5E,W_H(P?R!IUEJ6I>#-5>QN5,MMG<T?9E/\:>A/I]0?4>CV%_;:E:)=6D
M@DB?H1V/H1V-<\84ZO3ED;.4X>:/,K;^T;C2M5OKB:Z-S9B`1M*S;T^?)QGD
M8'/XTVVT[Q/K(`S?O$?XKB9E3'K\QY'T!KUBFNZHI9B%4#)).`!5?55UD3[?
MLCB-,^'D2$/J5UO/4Q0?*/Q8\G\`*FO=;LM&?^Q_#EE'+?.VP^6,JK>YZLP]
MSQW/&*SO$?B^;4)#IVCE_*8A#*@.^8GC:OH/U/TZ]%X6\-1Z):^;,%:^D7#L
M.1&/[B_U/?\`*I@HM\M)>K*E>W-4^XET/0#92-?ZA-]JU24?/,W(3_97T'Y?
M@.*W:*H:OJD>DV0G=#)))*D$,0.#)*[!57/;D\GL`3VKLA!+W8G/*3>K+]%9
M;KK:PETFT^24<^28G16_V=^XX_WMI_W:QKCQ1J8\%Q:O!I*_VE+<K;"Q>7[K
MF?RMI;U'<].O:K46]B;V.MHKBO%OB?6O"/AN/5;F#3[B9I5C:"/>%4D$\.3S
MT_NBK/B/6?$&B>'Y-8M;:QOXX8O-FBP\3*F,DCELXZGIP#]*:IMV\Q<QUE%%
M<MX6\81>(M7URQ557[!<!82!@R18QNY//S*QR.,%?QE1;3:Z#N=3117,^-_%
M:^$=)M[ORA*\MRD>S!/[O.9#Q_L@@=MS+]*(Q<G9`W;4Z:BFQR)-&LD;!D<!
ME8'((/0USGC/7;WPQH-QK$"6\\<31J('1E)W,%^^#[Y^[1&+D[(&[*YTM%<K
M=:YK-KX33Q#';V5U&+5;N6U^:)E3;N;:^6!(&?X1G%68/$RZMX7M]:TB%I5G
M8#RY!AD^;:P/.`00><X[YQ5<CW"Z.AHJ"TD>:UCDD7:S#)&TK^.#R/H>114#
M)Z***`"BBHIWD5<0QAW/3<VU1]3S^@-`&#XRTZUO=&,DSA+F(_Z.V,EV/\``
MY.['0>Q[5S?A>[L_#\I:\U`F:X(3[)#\ZIR!N=AP"/0'('KT'7'P]!>3BXU2
M5[V8`A5;*Q(#U"H#T/?<237#>-M'33=52:WC6.VN4RJH``C+@$`#IV/XFN*N
MI1?M4CII-27L[GJ5<EXMU&QN8Y-&DU%K.X*J^XJ3&^<X1R.0.Y_#KTKHM,NO
MMVEVEUWFA1S]2,FO,KJ%]?\`&\]N"<2W31DCLB<$_P#?*_G6F(G:"2ZD4H^\
MV^AM>!M*@CO)KFY=#>1C]S&""`AX,BGHP/3(X'/K7?5CR^&=-9TEMHFLIXSE
M);4["IQC./NGCCD'-7K8W<8$=ULE/::,;<_5>Q^F1].E72A[./+8FI+F?,6J
MYKQQH%YX@T%(=-N!!J%K<)=6SDX'F)G&3VZG'OBNEK%UWQ!;Z%>Z2MY*D5O?
M7!MC(YP%<J67)]RN/^!"NB%U*\=S)VMJ<0GQ+U[0-L7BWPO<Q*IVO=6XPI/M
MG*$_1Z[G0=6TCQ'I:7NF-')!YA)4IM:.7.X[E[-DYSWSD$YS6M(BR1M&ZAD8
M$,K#((/8BN%^'&CI877B*]M%V:7=WQ6R4?=:-"PWKVV$L0I[A1VQ6CY)1;2L
MT2KIV*WQJ_Y$5/\`K\3_`-!>N\MXTFTV*.1%>-X0K*PR&!'(([BN#^-7_(BI
M_P!?:?\`H+UW]G_QY0?]<U_E2E_"CZO]!KXF5-;N!!IYC$WDR7+"".0,%*EN
M"P)[JNYO^`UYQJDMMX4^+6FZK:R0_P!G:M$+681L"$(VIVX`&(C^#5Z,46]U
MEMPW16:8P0"ID?D_BJ@?A(:YSXF>'DU?P3=F"%1<6?\`I4>P8)"@[AQ_L%L#
MUQ3I-*5GU_44EI=':UQWB.SM?$NFZW9O/;A_*^S6H>11B52'+9[`N$4C_IG5
MKPSXF_M;P-:ZP0);D1>7(@(!>=3MVCTW-C'^\*V[/3X[>TBBD6.615^>0H,N
MYY9OJ3D_C4*\'YHK=')_"G6_[6\%P6\C'[1I[?9G#==HY3CTVD+]5-.^+7_)
M.[[_`*ZP?^C5K$T\#PC\9KRR(\NPUV+S8A_#YG+<_P#`A*,?[:UM_%K_`))U
M?G_IK!_Z-6MK+VT6MG9D7]QH@NKV\/POCMHM,N%272DB>Z<J8XD,0#2;4+.V
M`20`I)]NM;?@73M/TSPA8V^F7R7UL0S_`&I!@2,6)8XSQ@\8ZC&#R*N>&E#>
M$M(5@"#8P@@]_P!V*XOX,%H/#VJ:;*2)[34&5XR>4^11C';YE;\0:EZPEY,:
MT:/2J***P+"BBB@`HHHH`*Y[QK8?;?#<SJ,O;$3K]!PW_CI/Y5T-,EB2:)XI
M`&1U*L#W!X-3./-%Q*B^5IG/>#KL?\(C"[G_`%'F!OH&)_D16)\/+,RSWNIR
MC+`")6]S\S?^R_G3M"9K+P3K]O(?WMN\\9^NP#^>:Z#P?9_8_#-H",-,#,WO
MNY'Z8KEIKF<+]%_P#:;Y5+S9NT445V'.%136\-P,30QR#!&'4-P>#UJ6H+E[
M9%0W)C`)VKO[GT'OQ^E%[`5?[!TH1^5]@@\G&/)V_N\?[GW?TK0``&!T%5X8
M[.>)98DADC<95T`(8>H-1>9IVR9\V^V%MDAP,(WH?0\C\Z3D^H[!=:+I=\[/
M>:;9W#,06,T"N3@8&<CTJ6#3[.VC>."T@BCD&'6.(*&^H'6G-!;*I9H8PH&2
M=HZ5#;OIUW_Q[M;2G:'PFT_*>A^A[&CF>PK"P:3IUK+YMO86L,@_CCA56Z8Z
M@>E2W-E:WJJMU;0SA>@EC#8_.F3)9V\9DF6&-!@%F``Y.!^II(!8W._R1"Y1
MMKA0,J<9P1V."#^-',[A8KQ^'=$B39'H^GHN=V%M4`SZ]/85?A@BMHA%!$D4
M:_=1%"@?@*@(L1<BW*P^<5WB/`R5Z9QZ4Z9+.WC\R9(43(&Y@`,DX`_.AR;W
M"Q6D\/Z--())=)L'=3N#-;(2#USG%+)X?T:5"DFDV#J>JM;(1_*IH!8W(<PK
M"^QMKA0#M;`.#Z'!'YT]X;5"@:.%2YVJ"`-QP3@?@#^5/F8606EA9V(86EI!
M;A@`1#&$R!TZ>E0G1M,:^:^.G6AO&(+7!@7S#CIEL9XP,>E6/LMO_P`\8_\`
MOD5';BSG!DMQ"X5BNY`.&!P1]0:+L+%JBBB@`HHHH`****`"BBB@#AM5A:"'
MQ7;Q#'G/;R(/4R$`_J#7:V\*6UO'!&,)&@1?H!BL/4K8R:R1VG%K^/E3,Y_0
MBN@K&G&TG_75FDW=+^NB"BBBMC,*SM6MQ<QP`BX5DDWI/;D;X6VD;L'J,$C&
M#][IZ:-%)JZL-.Q4TO[3_9T'VQ$2YVYD5``,Y]!D`GJ>3S6?%#<0S:G`;>0_
M:;D21R#&W:4122<\8*GC\LUMT4N71!<9+Q$^`2=IX'4USV@6-W9-:F[@D9OL
M4<22$C]QM`W1D#KR,AN<].PSTE%#BFTP3LK&9JMO-)<:?<QQF9+6<R/$",D%
M&7(SP2"V<>F<<XJ33_M#7=]+*K+"\B^1N4*2H09)QS][(Y]*OT4<NMPOI8RW
MBE/B6&<1-Y*VCQF3L&+J0/R!I=6@F>YTZZCC:9+6<O)$I&2"C+N&>"1NSCTS
MCG`K3HHY4/F(;=@^^00M'N/)<`%N.N/\>>*R=9M+V_,AM]L;6J"2`NA;?*#N
M&.>/NA>G1F'2MRBAQNK,2=G<C@D:6!)'B:)F4$QMC*GT.*S-+>>WA,#V<P9[
MJ=\G`54:5V#$Y]"..N36O11;6X7"BBBJ$%%%%`!1110`4444`5)X-]_:2_\`
M//?G\15NBBE8`HHHI@%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
#!__9
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
